Home/Spotlight Medical/Christelle Baille

CB

Christelle Baille

Head of Quality & Regulatory Affairs

Spotlight Medical

Therapeutic Areas

Spotlight Medical Pipeline

Drug	Indication	Phase
AI-Powered Prognostic Assay for ER+/HER2- Early Breast Cancer	Early-stage, Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer	Validated

Leadership Team at Spotlight Medical

PhD Sylvain Berlemont

Cofounder & Chief Executive Officer

PhD Marvin Lerousseau

Cofounder & Chief Scientific Officer

View full Spotlight Medical profile